Displaying 121 - 132 of 275
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
General Hepatology
1

Alexion: Wilson Disease in Neurology, Hepatology and Psychiatry: The Great Chameleon - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
1

BioMarin: Gene therapy clinical trials for haemophilia: A partnership between haematologists and hepatologists - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
1

Ipsen: Current challenges in Primary Biliary Cholangitis (PBC): Debating the care odyssey - ILC 2022

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Displaying 121 - 132 of 275